EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSVVUG00000021817
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSVVUG00000004626
Gene Symbol: KIF5B
3 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSVVUG00000018982
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSVVUG00000029205
Gene Symbol: LTB4R
1 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSVVUG00000029204
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSVVUG00000026002
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSVVUG00000004974
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSVVUG00000019447
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSVVUG00000028671
Gene Symbol: MST1R
3 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSVVUG00000027858
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSVVUG00000027701
Gene Symbol: MGAM2
3 Cross references
390 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSVVUG00000011949
Gene Symbol: MMP1
3 Cross references
352 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).